Rupp RE - Search Results

1

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, Kavita U, Stanberry L, Shaw A. Turley CB, et al. Among authors: rupp re. Vaccine. 2011 Jul 18;29(32):5145-52. doi: 10.1016/j.vaccine.2011.05.041. Epub 2011 May 30. Vaccine. 2011. PMID: 21624416 Clinical Trial.

2

New biomedical approaches for sexually transmitted infection prevention: vaccines and microbicides.

Rupp R, Stanberry LR, Rosenthal SL. Rupp R, et al. Adolesc Med Clin. 2004 Jun;15(2):393-407. doi: 10.1016/j.admecli.2004.02.010. Adolesc Med Clin. 2004. PMID: 15449851 Review.

3

Pediatrics and herpes simplex virus vaccines.

Rupp R, Rosenthal SL, Stanberry LR. Rupp R, et al. Semin Pediatr Infect Dis. 2005 Jan;16(1):31-7. doi: 10.1053/j.spid.2004.09.009. Semin Pediatr Infect Dis. 2005. PMID: 15685147 Review.

4

Parental acceptance of adolescent vaccines within school-based health centres.

Short MB, Rupp R, Stanberry LR, Rosenthal SL. Short MB, et al. Herpes. 2005 Jun;12(1):23-7. Herpes. 2005. PMID: 16026641

5

Vaccines for sexually transmitted infections.

Rupp RE, Stanberry LR, Rosenthal SL. Rupp RE, et al. Pediatr Ann. 2005 Oct;34(10):818-20, 822-4. doi: 10.3928/0090-4481-20051001-14. Pediatr Ann. 2005. PMID: 16285635 Review.

6

VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.

Rupp R, Rosenthal SL, Stanberry LR. Rupp R, et al. Int J Nanomedicine. 2007;2(4):561-6. Int J Nanomedicine. 2007. PMID: 18203424 Free PMC article. Review.

7

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB. Frey SE, et al. Among authors: rupp re. J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16. J Infect Dis. 2012. PMID: 22802432 Free PMC article. Clinical Trial.

8

School-based vaccination of young US males: impact of health beliefs on intent and first dose acceptance.

Rickert VI, Auslander BA, Cox DS, Rosenthal SL, Rickert JA, Rupp R, Zimet GD. Rickert VI, et al. Vaccine. 2014 Apr 7;32(17):1982-7. doi: 10.1016/j.vaccine.2014.01.049. Epub 2014 Jan 31. Vaccine. 2014. PMID: 24492015

9

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.

Rupp R, Luckasen GJ, Kirstein JL, Osorio JE, Santangelo JD, Raanan M, Smith MK, Wallace D, Gordon GS, Stinchcomb DT. Rupp R, et al. Vaccine. 2015 Nov 17;33(46):6351-9. doi: 10.1016/j.vaccine.2015.09.008. Epub 2015 Sep 15. Vaccine. 2015. PMID: 26384447 Free article. Clinical Trial.

10

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.

Bernstein DI, Munoz FM, Callahan ST, Rupp R, Wootton SH, Edwards KM, Turley CB, Stanberry LR, Patel SM, Mcneal MM, Pichon S, Amegashie C, Bellamy AR. Bernstein DI, et al. Vaccine. 2016 Jan 12;34(3):313-9. doi: 10.1016/j.vaccine.2015.11.056. Epub 2015 Dec 2. Vaccine. 2016. PMID: 26657184 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page